Eastern and South-Eastern Asia vs Zimbabwe: Mortality rate attributed to cardiovascular disease, cancer, diabetes
Eastern and South-Eastern Asia
16.6
in 2021
Zimbabwe
31.2
in 2021
Eastern and South-Eastern Asia rank
14th
Zimbabwe rank
12th
Mortality rate attributed to cardiovascular disease, cancer, diabetes over time
- Eastern and South-Eastern Asia
- Zimbabwe
How they compare
Zimbabwe currently reports 31.2 against 16.6 in Eastern and South-Eastern Asia, a difference of 14.6.
That makes Zimbabwe's figure about 1.9 times Eastern and South-Eastern Asia's.
Across all 7 years both countries report, Zimbabwe has been ahead every year.
Eastern and South-Eastern Asia ranks 14th and Zimbabwe ranks 12th of 21 groups.
Zimbabwe has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Eastern and South-Eastern Asia | Zimbabwe | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 21.9 | 26.1 | 4.2 | Zimbabwe |
| 2010s | 17.8 | 33.33 | 15.53 | Zimbabwe |
| 2020s | 16.55 | 32.1 | 15.55 | Zimbabwe |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher mortality rate attributed to cardiovascular disease, cancer, diabetes, Eastern and South-Eastern Asia or Zimbabwe?
- Zimbabwe, at 31.2 against 16.6 in Eastern and South-Eastern Asia as of 2021.
- What is the difference in mortality rate attributed to cardiovascular disease, cancer, diabetes between Eastern and South-Eastern Asia and Zimbabwe?
- 14.6, with Zimbabwe ahead.
- How many years of comparable data are there for Eastern and South-Eastern Asia and Zimbabwe?
- 7 years are reported by both, from 2000 to 2021.
- How do Eastern and South-Eastern Asia and Zimbabwe rank globally for mortality rate attributed to cardiovascular disease, cancer, diabetes?
- Eastern and South-Eastern Asia ranks 14th and Zimbabwe ranks 12th of 21 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease (probability). Statizoid refreshes it automatically from the source and publishes the full history for both places.